Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2024 | 206 | 0.870 |
Why?
|
| Genome-Wide Association Study | 9 | 2024 | 421 | 0.690 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2024 | 727 | 0.670 |
Why?
|
| Lymphocytes | 1 | 2019 | 124 | 0.580 |
Why?
|
| Neutrophils | 1 | 2019 | 141 | 0.570 |
Why?
|
| DNA Mismatch Repair | 5 | 2024 | 28 | 0.560 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 158 | 0.520 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 211 | 0.500 |
Why?
|
| Colonic Neoplasms | 4 | 2024 | 223 | 0.420 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 860 | 0.390 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 150 | 0.340 |
Why?
|
| Colorectal Neoplasms | 6 | 2015 | 502 | 0.340 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 74 | 0.330 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1679 | 0.300 |
Why?
|
| Glucuronosyltransferase | 2 | 2019 | 29 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 60 | 0.280 |
Why?
|
| Genotype | 7 | 2020 | 796 | 0.240 |
Why?
|
| Registries | 7 | 2020 | 431 | 0.230 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2012 | 18 | 0.230 |
Why?
|
| Middle Aged | 18 | 2024 | 11819 | 0.210 |
Why?
|
| Aged | 16 | 2024 | 7982 | 0.210 |
Why?
|
| Humans | 32 | 2024 | 42163 | 0.190 |
Why?
|
| Female | 25 | 2024 | 24018 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 366 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2019 | 587 | 0.170 |
Why?
|
| Case-Control Studies | 7 | 2024 | 1266 | 0.160 |
Why?
|
| Nicotine | 1 | 2023 | 290 | 0.160 |
Why?
|
| Male | 19 | 2024 | 22779 | 0.160 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 585 | 0.150 |
Why?
|
| Risk Factors | 10 | 2024 | 3942 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 69 | 0.140 |
Why?
|
| Nitrosamines | 1 | 2018 | 11 | 0.140 |
Why?
|
| Glucuronides | 1 | 2018 | 23 | 0.140 |
Why?
|
| Estrogen Receptor beta | 2 | 2008 | 39 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 638 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2008 | 429 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 557 | 0.120 |
Why?
|
| Mutation | 3 | 2012 | 1169 | 0.120 |
Why?
|
| Adiposity | 1 | 2017 | 155 | 0.120 |
Why?
|
| Logistic Models | 3 | 2019 | 1001 | 0.120 |
Why?
|
| DNA Repair | 2 | 2008 | 196 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 479 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 406 | 0.110 |
Why?
|
| CpG Islands | 1 | 2015 | 107 | 0.110 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 22 | 0.100 |
Why?
|
| Obesity | 2 | 2023 | 1131 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 81 | 0.100 |
Why?
|
| Prognosis | 4 | 2024 | 850 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 83 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 168 | 0.100 |
Why?
|
| Haplotypes | 3 | 2008 | 197 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 2803 | 0.100 |
Why?
|
| Smoking | 2 | 2010 | 1019 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2485 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 25 | 0.090 |
Why?
|
| Survivors | 1 | 2013 | 152 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 101 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2015 | 393 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 674 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2020 | 1729 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2010 | 318 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 35 | 0.080 |
Why?
|
| Computational Biology | 1 | 2012 | 324 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 81 | 0.080 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 1 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 127 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 1068 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 17 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2020 | 103 | 0.070 |
Why?
|
| Asthma | 1 | 2011 | 410 | 0.070 |
Why?
|
| Adult | 10 | 2020 | 13458 | 0.070 |
Why?
|
| Microsatellite Instability | 3 | 2012 | 47 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 200 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 239 | 0.060 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 287 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 508 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 20 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2021 | 85 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 144 | 0.060 |
Why?
|
| Leucovorin | 1 | 2024 | 5 | 0.060 |
Why?
|
| Organoplatinum Compounds | 1 | 2024 | 18 | 0.050 |
Why?
|
| Morbidity | 1 | 2004 | 97 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2024 | 53 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2024 | 46 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 11 | 0.050 |
Why?
|
| Cause of Death | 1 | 2004 | 183 | 0.050 |
Why?
|
| Family Health | 2 | 2015 | 56 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2023 | 19 | 0.050 |
Why?
|
| Cotinine | 1 | 2023 | 44 | 0.050 |
Why?
|
| Life Style | 1 | 2004 | 326 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 209 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 933 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 173 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 230 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 454 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2010 | 845 | 0.040 |
Why?
|
| Family | 2 | 2013 | 192 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 88 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 143 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2020 | 90 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 4936 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 143 | 0.040 |
Why?
|
| Pedigree | 2 | 2013 | 94 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2012 | 32 | 0.040 |
Why?
|
| Follistatin | 1 | 2019 | 28 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 60 | 0.040 |
Why?
|
| United States | 3 | 2019 | 5072 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 77 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 118 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 121 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 404 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 928 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 190 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 206 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 139 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 692 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 34 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 2111 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 100 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 330 | 0.030 |
Why?
|
| Vitamin D | 1 | 2019 | 196 | 0.030 |
Why?
|
| Heterozygote | 2 | 2008 | 107 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 90 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 201 | 0.030 |
Why?
|
| Risk | 2 | 2008 | 289 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 267 | 0.030 |
Why?
|
| Proteins | 1 | 2018 | 383 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2598 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 5950 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 916 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 236 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 62 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 97 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 24 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 311 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2012 | 92 | 0.020 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 774 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 512 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 157 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 27 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 594 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 35 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 115 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 187 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 456 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 95 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1848 | 0.020 |
Why?
|
| Canada | 1 | 2008 | 157 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 212 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 91 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 352 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 487 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2005 | 9 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 2005 | 15 | 0.010 |
Why?
|
| SEER Program | 1 | 2005 | 157 | 0.010 |
Why?
|
| Pacific Islands | 1 | 2004 | 121 | 0.010 |
Why?
|
| Neoplasms | 2 | 2005 | 1341 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 255 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 245 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2004 | 456 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 531 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1597 | 0.010 |
Why?
|
| Hawaii | 1 | 2004 | 2004 | 0.010 |
Why?
|